Congcong Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Congcong Zhu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Tonghu Liu
5 shared publications- Zechen Yan
Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
3 shared publications - Jiyang An
Department of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
2 shared publications - Lili Zhou
Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
2 shared publications Zechen Yan
Institute of Molecular Cancer Surgery, Zhengzhou University, Henan Province Engineering Research Center, Zhengzhou, Henan, China
2 shared publications- Geping Wu1 shared publication
Latest Publications
- Open Access
- 1 August 2026
- Published by KEAI Publishing in Genes & Diseases
ZWINT as a central indicator of poor prognosis and immunosuppression in adrenocortical carcinoma
- 1 August 2026
- Published by KEAI Publishing in Genes & Diseases
Open AccessZWINT as a central indicator of poor prognosis and immunosuppression in adrenocortical carcinoma
- Open Access
- 13 January 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e79945
Neutrophil Percentage–to-Albumin Ratio as a Novel Prognostic Biomarker in Adult Diffuse Gliomas: Retrospective Study Integrating 3 Machine Learning Models and Cox Regression
Background: Adult-type diffuse glioma (ADG) is the most common primary malignant tumor of the central nervous system. Its highly invasive nature, marked heterogeneity, and resistance to therapy contribute to a high risk of recurrence and poor prognosis. At present, the lack of reliable prognostic tools poses a significant barrier to the development of individualized treatment strategies. Objective: This study aimed to develop an effective prognostic model for ADG by integrating multiple machine learning algorithms, in order to enhance the precision of individualized clinical decision-making. Methods: In this retrospective study, 160 newly diagnosed patients with ADG who underwent surgical resection and histopathological confirmation at our institution between June 2019 and September 2021 were included. A total of 32 variables, including clinical characteristics, molecular biomarkers, and preoperative hematological indicators, were collected. Overall survival (OS) and progression-free survival (PFS) were defined as the study endpoints. Feature selection was performed using least absolute shrinkage and selection operator regression, extreme gradient boosting, and random forest algorithms. Kaplan-Meier survival curves and log-rank tests were used for survival analysis. Multivariate Cox proportional hazards models were constructed to identify independent prognostic factors, and nomograms were developed accordingly. The model’s discriminative ability, calibration, and clinical utility were evaluated using the concordance index, area under the receiver operating characteristic curve (area under the curve), calibration plots, and Kaplan-Meier analysis. Results: Age, neutrophil percentage–to-albumin ratio (NPAR), and platelet-to-mean platelet volume ratio were identified as independent prognostic factors for OS, while age and NPAR were independent predictors for PFS (all P<.001). The prognostic models based on these variables demonstrated good predictive performance, with concordance index values of 0.731 and 0.763 for the training and validation cohorts in the OS model, respectively. The PFS model also showed robust performance. Area under the curve values and calibration curves further supported the models’ accuracy and stability. Risk stratification analysis revealed clear survival differences between risk groups (all P<.05), indicating strong clinical applicability. Conclusions: This study is the first to identify preoperative NPAR as a significant prognostic biomarker for ADG using machine learning approaches. The prognostic model incorporating NPAR, platelet-to-mean platelet volume ratio, and age demonstrated favorable predictive performance, offering a novel perspective for accurate risk stratification and personalized treatment in patients with ADG.
- 13 January 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e79945
Open AccessNeutrophil Percentage–to-Albumin Ratio as a Novel Prognostic Biomarker in Adult Diffuse Gliomas: Retrospective Study Integrating 3 Machine Learning Models and Cox Regression
Background: Adult-type diffuse glioma (ADG) is the most common primary malignant tumor of the central nervous system. Its highly invasive nature, marked heterogeneity, and resistance to therapy contribute to a high risk of recurrence and poor prognosis. At present, the lack of reliable prognostic tools poses a significant barrier to the development of individualized treatment strategies. Objective: This study aimed to develop an effective prognostic model for ADG by integrating multiple machine learning algorithms, in order to enhance the precision of individualized clinical decision-making. Methods: In this retrospective study, 160 newly diagnosed patients with ADG who underwent surgical resection and histopathological confirmation at our institution between June 2019 and September 2021 were included. A total of 32 variables, including clinical characteristics, molecular biomarkers, and preoperative hematological indicators, were collected. Overall survival (OS) and progression-free survival (PFS) were defined as the study endpoints. Feature selection was performed using least absolute shrinkage and selection operator regression, extreme gradient boosting, and random forest algorithms. Kaplan-Meier survival curves and log-rank tests were used for survival analysis. Multivariate Cox proportional hazards models were constructed to identify independent prognostic factors, and nomograms were developed accordingly. The model’s discriminative ability, calibration, and clinical utility were evaluated using the concordance index, area under the receiver operating characteristic curve (area under the curve), calibration plots, and Kaplan-Meier analysis. Results: Age, neutrophil percentage–to-albumin ratio (NPAR), and platelet-to-mean platelet volume ratio were identified as independent prognostic factors for OS, while age and NPAR were independent predictors for PFS (all P<.001). The prognostic models based on these variables demonstrated good predictive performance, with concordance index values of 0.731 and 0.763 for the training and validation cohorts in the OS model, respectively. The PFS model also showed robust performance. Area under the curve values and calibration curves further supported the models’ accuracy and stability. Risk stratification analysis revealed clear survival differences between risk groups (all P<.05), indicating strong clinical applicability. Conclusions: This study is the first to identify preoperative NPAR as a significant prognostic biomarker for ADG using machine learning approaches. The prognostic model incorporating NPAR, platelet-to-mean platelet volume ratio, and age demonstrated favorable predictive performance, offering a novel perspective for accurate risk stratification and personalized treatment in patients with ADG.
- 15 December 2025
- Published by Elsevier in European Urology Focus
Re: Heidi Fettke, Louise Kostos, Maria Docanto, et al. Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.015
- 15 December 2025
- Published by Elsevier in European Urology Focus
Re: Heidi Fettke, Louise Kostos, Maria Docanto, et al. Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.015
- Open Access
- 8 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8809-8810
Commentary on “The regulatory role and mechanism of TGFBI on Tregs in the immune microenvironment of clear cell renal cell carcinom”
- 8 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8809-8810
Open AccessCommentary on “The regulatory role and mechanism of TGFBI on Tregs in the immune microenvironment of clear cell renal cell carcinom”
- Open Access
- 5 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8813-8814
Commentary on “Association between prophylactic antibiotics and post-ablation infections in renal cell carcinoma patients: a retrospective multicenter cohort study”
- 5 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8813-8814
Open AccessCommentary on “Association between prophylactic antibiotics and post-ablation infections in renal cell carcinoma patients: a retrospective multicenter cohort study”
- Open Access
- 27 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8755-8756
Comments on “Integrated transcriptomic analysis identifies MZT2A as a prognostic and immune-related biomarker in KIRC”
- 27 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8755-8756
Open AccessComments on “Integrated transcriptomic analysis identifies MZT2A as a prognostic and immune-related biomarker in KIRC”
- Open Access
- 1 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Neutrophil Percentage–to-Albumin Ratio as a Novel Prognostic Biomarker in Adult Diffuse Gliomas: Retrospective Study Integrating 3 Machine Learning Models and Cox Regression (Preprint)
BACKGROUND Adult-type diffuse glioma (ADG) is the most common primary malignant tumor of the central nervous system. Its highly invasive nature, marked heterogeneity, and resistance to therapy contribute to a high risk of recurrence and poor prognosis. At present, the lack of reliable prognostic tools poses a significant barrier to the development of individualized treatment strategies. OBJECTIVE This study aimed to develop an effective prognostic model for ADG by integrating multiple machine learning algorithms, in order to enhance the precision of individualized clinical decision-making. METHODS In this retrospective study, 160 newly diagnosed patients with ADG who underwent surgical resection and histopathological confirmation at our institution between June 2019 and September 2021 were included. A total of 32 variables, including clinical characteristics, molecular biomarkers, and preoperative hematological indicators, were collected. Overall survival (OS) and progression-free survival (PFS) were defined as the study endpoints. Feature selection was performed using least absolute shrinkage and selection operator regression, extreme gradient boosting, and random forest algorithms. Kaplan-Meier survival curves and log-rank tests were used for survival analysis. Multivariate Cox proportional hazards models were constructed to identify independent prognostic factors, and nomograms were developed accordingly. The model’s discriminative ability, calibration, and clinical utility were evaluated using the concordance index, area under the receiver operating characteristic curve (area under the curve), calibration plots, and Kaplan-Meier analysis. RESULTS Age, neutrophil percentage–to-albumin ratio (NPAR), and platelet-to-mean platelet volume ratio were identified as independent prognostic factors for OS, while age and NPAR were independent predictors for PFS (all P<.001). The prognostic models based on these variables demonstrated good predictive performance, with concordance index values of 0.731 and 0.763 for the training and validation cohorts in the OS model, respectively. The PFS model also showed robust performance. Area under the curve values and calibration curves further supported the models’ accuracy and stability. Risk stratification analysis revealed clear survival differences between risk groups (all P<.05), indicating strong clinical applicability. CONCLUSIONS This study is the first to identify preoperative NPAR as a significant prognostic biomarker for ADG using machine learning approaches. The prognostic model incorporating NPAR, platelet-to-mean platelet volume ratio, and age demonstrated favorable predictive performance, offering a novel perspective for accurate risk stratification and personalized treatment in patients with ADG.
- 1 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessNeutrophil Percentage–to-Albumin Ratio as a Novel Prognostic Biomarker in Adult Diffuse Gliomas: Retrospective Study Integrating 3 Machine Learning Models and Cox Regression (Preprint)
BACKGROUND Adult-type diffuse glioma (ADG) is the most common primary malignant tumor of the central nervous system. Its highly invasive nature, marked heterogeneity, and resistance to therapy contribute to a high risk of recurrence and poor prognosis. At present, the lack of reliable prognostic tools poses a significant barrier to the development of individualized treatment strategies. OBJECTIVE This study aimed to develop an effective prognostic model for ADG by integrating multiple machine learning algorithms, in order to enhance the precision of individualized clinical decision-making. METHODS In this retrospective study, 160 newly diagnosed patients with ADG who underwent surgical resection and histopathological confirmation at our institution between June 2019 and September 2021 were included. A total of 32 variables, including clinical characteristics, molecular biomarkers, and preoperative hematological indicators, were collected. Overall survival (OS) and progression-free survival (PFS) were defined as the study endpoints. Feature selection was performed using least absolute shrinkage and selection operator regression, extreme gradient boosting, and random forest algorithms. Kaplan-Meier survival curves and log-rank tests were used for survival analysis. Multivariate Cox proportional hazards models were constructed to identify independent prognostic factors, and nomograms were developed accordingly. The model’s discriminative ability, calibration, and clinical utility were evaluated using the concordance index, area under the receiver operating characteristic curve (area under the curve), calibration plots, and Kaplan-Meier analysis. RESULTS Age, neutrophil percentage–to-albumin ratio (NPAR), and platelet-to-mean platelet volume ratio were identified as independent prognostic factors for OS, while age and NPAR were independent predictors for PFS (all P<.001). The prognostic models based on these variables demonstrated good predictive performance, with concordance index values of 0.731 and 0.763 for the training and validation cohorts in the OS model, respectively. The PFS model also showed robust performance. Area under the curve values and calibration curves further supported the models’ accuracy and stability. Risk stratification analysis revealed clear survival differences between risk groups (all P<.05), indicating strong clinical applicability. CONCLUSIONS This study is the first to identify preoperative NPAR as a significant prognostic biomarker for ADG using machine learning approaches. The prognostic model incorporating NPAR, platelet-to-mean platelet volume ratio, and age demonstrated favorable predictive performance, offering a novel perspective for accurate risk stratification and personalized treatment in patients with ADG.